PrismaSol Solution
FDA Approves Procysbi for Rare Genetic Condition »
"The U.S. Food and Drug Administration today approved Procysbi (cysteamine bitartrate) for the management of nephropathic cystinosis in children and adults. Procysbi was granted orphan product designation because it is intended to treat a rare dis"...
Read the FDA Approves Procysbi for Rare Genetic Condition article »
PrismaSol Solution
CLINICAL PHARMACOLOGY
PrismaSol solution (sterile hemofiltration hemodiafiltration solution) is a pharmacologically inactive solution. The electrolyte concentrations in the PrismaSol solution (sterile hemofiltration hemodiafiltration solution) are chosen to restore plasma levels to clinically desired concentrations or maintain plasma levels at the desired concentrations.
PrismaSol solution (sterile hemofiltration hemodiafiltration solution) is used as replacement solution to replace water and electrolytes removed during hemofiltration and hemodiafitration.
Bicarbonate in the solution is used as an alkalinizing buffer to normalize acid-base balance. Lactate is used for the adjustment of the solution pH and is metabolized to bicarbonate.
When dextrose is present, it is intended to help normalize glucose balance.
Last reviewed on RxList: 12/29/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional PrismaSol Solution Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
